Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-08-042520
Filing Date
2008-07-29
Accepted
2008-07-29 17:07:03
Documents
2
Period of Report
2008-07-28

Document Format Files

Seq Description Document Type Size
1 v121173_ex.html 4  
1 v121173_ex.xml 4 33212
2 v121173_ex99-1.htm EX-99.1 71757
  Complete submission text file 0001144204-08-042520.txt   107418
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
SEATTLE GENETICS INC /WA (Issuer) CIK: 0001060736 (see all company filings)

EIN.: 911874389 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 270 PARK AVENUE NEW YORK NY 10017
Business Address 270 PARK AVENUE NEW YORK NY 10017 212-270-7690
H&Q Employee Venture Fund 2000, L.P. (Reporting) CIK: 0001420958 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-32405 | Film No.: 08976546

Mailing Address 270 PARK AVENUE NEW YORK NY 10017
Business Address 270 PARK AVENUE NEW YORK NY 10017 212-270-7690
H&Q Holdings, Inc. (Reporting) CIK: 0001420959 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-32405 | Film No.: 08976547